scispace - formally typeset
M

Michael B. Sporn

Researcher at Dartmouth College

Publications -  561
Citations -  96644

Michael B. Sporn is an academic researcher from Dartmouth College. The author has contributed to research in topics: Transforming growth factor & Transforming growth factor beta. The author has an hindex of 157, co-authored 559 publications receiving 94605 citations. Previous affiliations of Michael B. Sporn include Cornell University & Reata Pharmaceuticals.

Papers
More filters
Journal ArticleDOI

13-cis-retinoic acid: inhibition of bladder carcinogenesis in the rat.

TL;DR: Feeding of the synthetic retinoid, 13-Cis-retinoid acid, inhibited the incidence and extent of bladder cancer in these rats, even when 13-cis- retinoic acid administration was begun after completion of the carcinogen treatment.
Journal ArticleDOI

Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages

TL;DR: 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO) was 400 times more potent than previous compounds made as an inhibitor of production of nitric oxide induced by interferon-gamma in mouse macrophages.
Journal ArticleDOI

TGF-β1 Prevents Hypertrophy of Epiphyseal Chondrocytes: Regulation of Gene Expression for Cartilage Matrix Proteins and Metalloproteases

TL;DR: It is proposed that one function of TGF-beta 1 during endochondral ossification is regulation of chondrocyte growth and differentiation through modulation of the relative expression of cartilage matrix proteins and metalloproteases.

Transforming growth factors from neoplastic and nonneoplastic tissues.

TL;DR: TGF-beta, isolated from bovine sources, accelerates experimental wound healing in rats and can be classified as type alpha or type beta based on their interactions with the receptor for epidermal growth factor and their requirement for EGF (or an EGF-like polypeptide) for functional activity.